Can Fever Trigger Respiratory Distress in Children with Myasthenia Gravis on Pyridostigmine?
Yes, fever can precipitate myasthenic crisis and respiratory distress in children with myasthenia gravis, representing a potentially life-threatening emergency that requires immediate recognition and intervention.
Why Fever is Dangerous in Myasthenia Gravis
Fever acts as a physiological stressor that can unmask or worsen underlying myasthenic weakness. The evidence demonstrates that all grades of myasthenia gravis warrant immediate work-up and intervention given the potential for progressive disease to lead to respiratory compromise 1, 2. This is particularly critical because there is no "grade 1" (mild) toxicity classification for myasthenia gravis—any symptom progression can rapidly evolve into respiratory failure.
The mechanism involves increased metabolic demands during febrile illness, which can overwhelm the already compromised neuromuscular transmission at the acetylcholine receptor level. A case report 3 specifically documented how fever triggered myasthenic crisis requiring artificial ventilation, demonstrating the direct causal relationship between fever and respiratory decompensation.
Critical Recognition Points
When a child with myasthenia gravis develops fever, you must immediately assess for:
- Respiratory muscle weakness: Monitor negative inspiratory force and vital capacity 1, 2
- Bulbar symptoms: ANY dysphagia or facial weakness indicates grade 3-4 disease 1
- Rapidly progressive symptoms: Even if currently mild, progression can be swift
- Signs of respiratory distress: Markedly raised respiratory rate, grunting, intercostal recession, breathlessness 4
Immediate Management Algorithm
If Fever with Stable Myasthenic Symptoms:
- Continue pyridostigmine at current dose
- Aggressively treat the fever source (infection workup)
- Avoid medications that worsen myasthenia: β-blockers, IV magnesium, fluoroquinolones, aminoglycosides, and macrolides 1, 2, 5
- Perform pulmonary function testing (negative inspiratory force, vital capacity) 1, 2
- Consider neurology consultation with low threshold for admission
If Fever with ANY Worsening Weakness:
- Admit immediately with capability for ICU-level monitoring 1, 2
- Initiate corticosteroids (prednisone 0.5-1.5 mg/kg/day) 2
- Continue pyridostigmine unless intubation required 5
- Prepare for IVIG (2 g/kg over 5 days) or plasmapheresis if grade 3-4 1, 2
- Frequent pulmonary function assessment 1
- Daily neurologic evaluation 1
If Respiratory Distress Present:
- This is grade 3-4 myasthenic crisis
- ICU admission mandatory 1, 2
- Corticosteroids PLUS IVIG or plasmapheresis immediately 1, 2
- May need to discontinue pyridostigmine if intubated 5
- Consider rituximab if refractory 2
Critical Pitfall: Distinguishing Myasthenic from Cholinergic Crisis
The FDA label for pyridostigmine warns that overdosage may result in cholinergic crisis, characterized by increasing muscle weakness which, through involvement of respiratory muscles, may lead to death 6. During fever, increased weakness could represent either:
- Myasthenic crisis (disease worsening) → needs MORE pyridostigmine
- Cholinergic crisis (pyridostigmine overdose) → needs WITHDRAWAL of pyridostigmine
This differentiation requires edrophonium testing and clinical judgment 6. However, in the acute setting with fever and respiratory compromise, err on the side of treating as myasthenic crisis with corticosteroids and IVIG/plasmapheresis while holding pyridostigmine temporarily, as this approach addresses both possibilities.
Special Pediatric Considerations
Children with fever >38.5°C and respiratory distress require immediate hospital admission 4. The combination of myasthenia gravis and fever places them at extreme risk. One case report 7 highlighted how respiratory distress in a child with myasthenia was initially misdiagnosed as Guillain-Barré syndrome, emphasizing the need for high clinical suspicion.
Bottom line: Fever in a child with myasthenia gravis on pyridostigmine is a medical emergency requiring immediate assessment of respiratory function, aggressive fever management while avoiding contraindicated antibiotics, and a very low threshold for ICU admission and immunomodulatory therapy.